EmeraMed   Report issue

For profit Phase 2 Phase 3
Founded: Dublin Ireland (2007)

Organization Overview

First Clinical Trial
2015
NCT02486289
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

EmeraMed